Alkem Laboratories incorporated a 100% wholly owned subsidiary, Alkem Pharmaceuticals Scientific Office FZ LLC, in Dubai Healthcare City, UAE on 4th February 2026.
The WOS has an authorized and subscribed share capital of AED 3,670,000 (3,670 equity shares of AED 1,000 each), funded via cash consideration.
The entity is set up for manufacturing products and obtaining product registrations (excluding trading), with UAE Ministry of Health approvals reportedly delayed due to regional conflict.